drugset
drugset / Trial / NCT00540722

Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

NCT00540722 ↗

Phase 2 Completed 56 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

This phase II trial is studying how well gossypol works in treating patients with progressive or recurrent glioblastoma multiforme. Gossypol may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Timeline

Start
2008-01
Primary completion
2012-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject R-(-)-Gossypol Unknown — Oral

Indications

adult glioblastoma giant cell glioblastoma gliosarcoma